Sign In
Buy MRVSY
$3.15
-0.0600 (-1.87%)
At Close: Jun 03, 2026
Minerva S.A. (MRVSY) Q3 2025 Earnings Call Transcript
12:06pm, Thursday, 06'th Nov 2025
Minerva S.A. (OTCPK:MRVSY) Q3 2025 Earnings Call November 6, 2025 7:00 AM EST Company Participants Fernando De Queiroz - Chief Executive Officer Edison de Andrade Melo e Souza Filho - Chief Financial
Minerva Foods' free cash flow reaches R$2.5 billion in the third quarter of 2025.
06:03pm, Wednesday, 05'th Nov 2025
This represents the highest level recorded by the Company in a single quarter. During the period, leverage declined to 2.5x, its lowest level since 2022 SÃO PAULO,, Nov. 5, 2025 /PRNewswire/ -- Miner
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
07:30am, Wednesday, 05'th Nov 2025
BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ner
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved
08:00am, Tuesday, 21'st Oct 2025
Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of Tranche A warrants. Minerva and the FDA have defined a path forward for roluperidone's clinical
Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results
04:35pm, Thursday, 14'th Aug 2025
FDA confirms requirement for confirmatory study of roluperidone for the treatment of negative symptoms in schizophrenia
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
07:30am, Tuesday, 13'th May 2025
BURLINGTON, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ner
MINERVA FOODS FILES FREE CASH FLOW OF R$ 990 MILLION IN THE FOURTH QUARTER OF 2024
07:09pm, Wednesday, 19'th Mar 2025
In 2024, free cash flow totals R$ 2.4 billion, which means a free cash flow yield (annualized) of approximately 85% p.a. The company has accumulated around R$ 9 billion in free cash generation since 2
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
07:00am, Tuesday, 25'th Feb 2025
BURLINGTON, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ne
MINERVA FOODS'S FILES NET PROFIT OF R$ 94.1 MILLION IN THE THIRD QUARTER OF 2024
05:43pm, Wednesday, 06'th Nov 2024
In the period, net revenue totaled R$ 8.5 billion and EBITDA was R$ 813 million BARRETOS, Brazil , Nov. 6, 2024 /PRNewswire/ -- Minerva Foods (Minerva S.A. – B3: BEEF3 | OTC – Nasdaq International
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
07:30am, Tuesday, 05'th Nov 2024
BURLINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ner
Minerva Launches Availability of Advanced, Real-time AML Screening Technology in AWS Marketplace
08:00am, Tuesday, 10'th Sep 2024
TORONTO--(BUSINESS WIRE)--Minerva Launches Availability of Advanced, Real-time AML Screening Technology in AWS Marketplace.
Minerva: Rise Of A Monopsony
10:45am, Friday, 19'th Jan 2024
Minerva S.A. is South America's largest export beef meatpacker with a significant market share in Brazil, Paraguay, Uruguay, and Colombia. The company enjoys scale advantages and operates as a monopso
MINERVA FOODS FILES EBITDA OF BRL 713,7 MILLION AND NET PROFIT OF BRL 141 MILLION IN 3Q23
05:28pm, Wednesday, 08'th Nov 2023
Free Cash Flow is up in the third quarter of 2023, at BRL 608,1 million, and BRL 1,2 billion in the last 12 months ending in September. BARRETOS, Brasil, Nov. 8, 2023 /PRNewswire/ -- Minerva Foods (Mi
MINERVA FOODS ACQUIRES CATTLE AND LAMB SLAUGHTER AND DEBONING PLANTS FROM MARFRIG IN SOUTH AMERICA
07:55pm, Monday, 28'th Aug 2023
The BRL 7.5 billion investment will increase the company's slaughtering capacity to over 42,000 head a day. With the move, the company reinforces its leadership in the beef market in South America and
MINERVA FOODS POSTS CONSOLIDATED GROSS REVENUE OF R$ 7,8 BILLION IN THE SECOND QUARTER OF 2023
07:02pm, Wednesday, 09'th Aug 2023
EBITDA was R$ 711,2 million and net revenue R$ 7,3 billion in the period SÃO PAULO, Aug. 9, 2023 /PRNewswire/ -- Minerva Foods (Minerva S.A. – B3: BEEF3 | OTC – Nasdaq International: MRVSY), a
